Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115712) titled 'A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safety of Voriconazole Ear Drops in the Treatment of Otomycosis' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Third Xiangya Hospital of Central South University
Condition:
Otomycosis
Intervention:
Control group:Treatment with placebo
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2023-03-30
Target Sample Size: Control group:36;Experimental group:72;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...